Abstract
Nischarin is an integrin-binding protein known as a novel tumor suppressor. In breast cancer, Nischarin plays a critical role in cell migration and invasion. However, the molecular mechanism underlying its role remains unclear. Recent findings suggest that the epithelial-mesenchymal transition (EMT) increases cell migration and invasion capacity. This study hypothesized that Nischarin regulates cellular processes via signaling pathways associated with the EMT process. By detecting mRNA and protein levels of EMT regulators following NISCH-overexpression and knockdown, the results demonstrated that Nischarin inhibits cell proliferation, migration, and invasion. Specifically, NISCH overexpression increased E-cadherin levels while decreasing transcription factors like Snail, ZEB1, N-cadherin, Slug, Twist1, and vimentin. These effects were reversed upon NISCH silencing, indicating that Nischarin suppresses metastasis by inhibiting the EMT process.
Introduction
Metastasis is the primary cause of mortality in breast cancer patients. A pivotal step in this progression is the Epithelial-Mesenchymal Transition (EMT), where stationary epithelial cells transform into mobile, invasive mesenchymal cells. While Nischarin was previously identified as a tumor suppressor, its specific influence on the genetic regulators of EMT, particularly in aggressive triple-negative breast cancer (TNBC) subtypes, required further elucidation.
Experimental Validation
To investigate these mechanisms, researchers utilized two human TNBC cell lines: Hs578T (characterized by low endogenous Nischarin) and MDA-MB-231 (higher endogenous Nischarin). They employed a "push-pull" experimental design to observe the effects of varying Nischarin levels.
As shown in the figure above, Nischarin levels were successfully boosted in Hs578T cells using a pcDNA3.1-Nischarin plasmid (overexpression) and significantly reduced in MDA-MB-231 cells using small interfering RNA (siRNA) knockdown. These manipulations provided the foundation for measuring changes in EMT markers.
Key Insights: Nischarin as a Master Regulator
The study's most significant finding is that Nischarin acts as a master regulator of the EMT network. It does not merely affect a single marker but influences a suite of EMT-inducing transcription factors, including Snail, ZEB1, Slug, and Twist1.
- Restoration of Epithelial Characteristics: Overexpression of Nischarin leads to an increase in E-cadherin, the protein responsible for cell-to-cell adhesion, effectively "gluing" cells in place.
- Suppression of Mesenchymal Markers: Simultaneously, Nischarin suppresses mesenchymal markers such as Vimentin and N-cadherin, which are associated with increased motility and invasiveness.
- Anti-Metastatic Focus: Interestingly, while Nischarin significantly inhibited migration and invasion in functional assays, its impact on short-term cell proliferation was minimal. This suggests its primary therapeutic potential lies in preventing metastasis rather than just reducing primary tumor growth.
Conclusion and Future Directions
The results confirm that Nischarin suppresses cell migration and invasion by inhibiting the EMT process. However, some limitations remain. While mRNA changes were consistent across all seven tested EMT markers, protein-level confirmation was only achieved for Twist1, Slug, and Vimentin. Furthermore, the specific signaling pathways (such as TGF-β or Wnt) through which Nischarin exerts these effects are yet to be mapped. Future research involving in vivo animal models is necessary to validate these findings within a complex biological environment.
Summary updated